These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17085372)

  • 1. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D; Barros H; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
    Zárate A
    Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM; Sakkas EG; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
    Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Last word on hormone replacement and breast cancer?].
    Rookus MA; van Leeuwen FE; Hamerlynck JV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):111-3. PubMed ID: 9557006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy and cancer].
    Bjørge T; Tropé C
    Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The controversy of hormone-replacement therapy in breast cancer survivors.
    Snyder GM; Sielsch EC; Reville B
    Oncol Nurs Forum; 1998 May; 25(4):699-706; quiz 707-8. PubMed ID: 9599353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in breast cancer patients and survivors.
    Del Priore G; Hatami M
    Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer surveillance during HRT.
    Palacios S
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
    Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
    Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
    Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
    Harefuah; 2002 Nov; 141(11):994-6, 1008. PubMed ID: 12476637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.